News
Cyclophosphamide after transplant reduced GVHD in myeloma patients
Anticancer agents may be more active after transplantation than before, researchers suggested.
News
Lung injury risk higher with apheresis blood products
Compared with other red blood cell products, those derived from apheresis significantly increased pulmonary cell interleukin-6 and interleukin-8...
News
Perioperative blood transfusion linked to worse outcomes in renal cell carcinoma
PBT increased the risk of tumor recurrence, metastatic progression, and death in patients undergoing nephrectomy for RCC.
News
Event-free survival at 24 months predicts outcomes in peripheral T-cell lymphomas
Event-free survival at 24 months (EFS24) is predictive of survival in patients with peripheral T-cell lymphomas (PTCLs), according to new findings...
News
Cold stored platelets control bleeding after complex cardiac surgery
SAN DIEGO – As measured by chest drain output after chest closure, patients who received cold stored platelets had a significantly lower median...
News
Citrate reactions seen in 7% of apheresis donations
SAN DIEGO – Prophylactic oral or intravenous calcium supplements can correct decreased ionized calcium levels and manage the symptoms of...
News
State regulations for tattoo facilities increased blood donor pools
SAN DIEGO – Accepted donors with tattoos increased 13-fold in California and 3-fold in Arizona after statewide regulations were enacted.
News
Still too early to determine impact of 1-year deferral for MSM blood donors
The rates of deferral were evaluated in two 7-month periods before and after the policy change.
News
Measures needed to identify past pregnancy in transgender male blood donors
If HLA testing is not performed in these cases, male blood recipients can potentially be placed at risk.
News
Adding bortezomib to R-CHOP didn’t improve survival in diffuse large B-cell lymphoma
Could the phase-2 PYRAMID trial’s bortezomib dosing explain the lack of significant benefit?
News
Eribulin superior to dacarbazine in advanced liposarcoma
Overall survival with eribulin was 15.6 versus 8.4 months with dacarbazine in a phase 3 randomized trial of 452 patients with advanced liposarcoma...
News
In Hodgkin lymphoma, HAPLO transplant outcomes match those of conventional transplants
HAPLO transplants may prove a better option than HLA-matched unrelated donor transplants.
News
Physician burnout common, not readily recognized
CHICAGO – Stress can push you to perform, but burnout just leaves you burnt.
News
Physician burnout common, not readily recognized by sufferers
CHICAGO – “But burnout is a very slow and insidious process. A lot of the time we don’t recognize it. . ."
News
No survival benefit with adjuvant girentuximab in high-risk RCC
Adjuvant therapy with girentuximab failed to improve either disease-free or overall survival, compared with placebo, in a cohort of patients in...